Inventor · disambiguated record
Yubin Lv
Also filed as: LV YUBIN
6 granted patents·2 pending applications·1 citations·filing 2016–2022
67Inventor score
Files withHANGZHOU HUADONG MEDICINE GROUP BIOPHARMACEUTICAL CO LTD3HANGZHOU BIOSUN PHARMACEUTICAL CO LTD1HANGZHOU SANYINTAI PHARMACEUTICAL TECH CO LTD1LIAO XIBIN1SHANGHAI HONGCHENG PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
8 records- 0164US10065931B2Quinazolin crotyl compound dimaleate crystals and preparation methods and uses thereofHANGZHOU HUADONG MEDICINE GROUP BIOPHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 4, 2018·1 cites·16 claims
- 0258US2025049941A1ANTI-CD39 Antibody-Drug Conjugate And Use ThereofSHANGHAI HONGCHENG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0355US12486229B2Indole derivative and application thereofSHANGHAI MEDICILON INC·Filed 2021·Granted Dec 2, 2025·0 cites·3 claims
- 0453US10640470B2Quinazolin crotyl compound dimaleate crystals and preparation methods and uses thereofHANGZHOU HUADONG MEDICINE GROUP BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted May 5, 2020·0 cites·12 claims
- 0549US12435079B2Bruton's tyrosine kinase inhibitorsLIAO XIBIN·Filed 2020·Granted Oct 7, 2025·0 cites·2 claims
- 0647US2024124469A1Pim kinase inhibitorHANGZHOU BIOSUN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0740US10822339B2Pyrrolopyrimidine five-membered azacyclic derivative and application thereofHANGZHOU HUADONG MEDICINE GROUP BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 3, 2020·0 cites·13 claims
- 0829US10640512B2Imidazopyrazinamine phenyl derivative and use thereofHANGZHOU SANYINTAI PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted May 5, 2020·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Yubin Lv files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →